A Population Physiologically Based Pharmacokinetic/Pharmacodynamic Model for the Inhibition of 11-β-Hydroxysteroid Dehydrogenase Activity by Glycyrrhetic Acid
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 170 (1) , 46-55
- https://doi.org/10.1006/taap.2000.9078
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and PerspectivesPharmaceutical Research, 1999
- Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urineExperimental and Clinical Endocrinology & Diabetes, 1999
- Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β‐hydroxysteroid dehydrogenase in vivoClinical Endocrinology, 1997
- Further studies on the mechanism of the mineralocorticoid action of licorice in humansJournal of Endocrinological Investigation, 1996
- Physiologic indirect response models characterize diverse types of pharmacodynamic effectsClinical Pharmacology & Therapeutics, 1994
- Inhibition of rat renal 11β-hydroxysteroid dehydrogenase by steroidal compounds and triterpenoids; structure/function relationshipBiochimica et Biophysica Acta (BBA) - General Subjects, 1991
- Pharmacokinetics and Oral Bioavailability of HydrocortisoneThe Journal of Clinical Pharmacology, 1991
- The Influence of Glycyrrhetinic Acid on Plasma Cortisol and Cortisone in Healthy Young VolunteersJournal of Clinical Endocrinology & Metabolism, 1990
- Binding of glycyrrhetinic acid to rat plasma, rat serum albumin, human serum, and human serum albumin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- A Bayesian analysis of the minimum AIC procedureAnnals of the Institute of Statistical Mathematics, 1978